Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Gliosarcoma 131Glioblastoma 128Central Nervous System Neoplasms 58Glioma 51Brain Neoplasms 48Astrocytoma 45Oligodendroglioma 32Sarcoma 23Sarcoma, Ewing 22Rhabdomyosarcoma 18Neuroblastoma 14Medulloblastoma 14Ependymoma 14Osteosarcoma 10Neoplasms 6Choroid Plexus Neoplasms 6Wilms Tumor 5Recurrence 5Ovarian Neoplasms 5Neuroectodermal Tumors, Primitive, Peripheral 5Glioma, Subependymal 5Familial ependymoma 5Rhabdoid Tumor 4Pinealoma 4Optic Nerve Glioma 4Neuroectodermal Tumors, Primitive 4Leiomyosarcoma 4Diffuse Intrinsic Pontine Glioma 4Testicular Neoplasms 3Kidney Neoplasms 3

Interventions

Doxorubicin 17Ifosfamide 12Radiotherapy 8pazopanib 5selinexor 4pembrolizumab 4Filgrastim 4pegfilgrastim 3Sirolimus 3Nivolumab 3Magnetic Resonance Spectroscopy 3Imatinib Mesylate 3Etoposide 3AZD 6244 3fludarabine phosphate 2brostallicin 2X-Rays 2Trabectedin 2Specimen Handling 2Sorafenib 2Radiation Dose Hypofractionation 2Radiation 2Diathermy 2Chemotherapy, Adjuvant 2Biopsy 2thymoglobulin 1temsirolimus 1tazemetostat 1sotigalimab 1sapanisertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibrosarcoma × Temozolomide × Sarcoma × Clear all
NCT00003718 2014-01-06

Temozolomide in Treating Patients With Advanced Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 2 Unknown
25 enrolled
GynecologicSarcoma

Malignant mesenchymal tumor, Hemangiopericytoma, Malignant, Chondrosarcoma, Extraskeletal Myxoid, Fibrosarcoma, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Ovarian Neoplasms, Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial, Endometrial Neoplasms, Sarcoma, Endometrial Stromal, Sarcoma, Alveolar Soft Part, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡